Cases & Deals

sanofi-aventis enters into $900 million R&D/equity

Clients sanofi-aventis S.A.

Jones Day advised sanofi-aventis in its $400 million global biotech collaboration arrangement with and equity investment in Regeneron, with up to $475 million of additional research funding.